Thermo Fisher ScientificMIL:1TMO +0.91%57 EV-to-Revenue is 4.83 as of Jun. 24, 2026, which is 10% below its 10-year median of 5.37. GuruFocus rates MIL:1TMO with a GF Score™ of 57/100 and a GF Value™ of €507.22 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Thermo Fisher Scientific ranks worse than 63.73% on this metric.
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Thermo Fisher Scientific's enterprise value is €187,679 Mil.
Thermo Fisher Scientific's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was €38,837 Mil. Therefore, Thermo Fisher Scientific's EV-to-Revenue for today is 4.83.
The historical rank and industry rank for Thermo Fisher Scientific's EV-to-Revenue or its related term are showing as below:
MIL:1TMO'
s EV-to-Revenue Range Over the Past 10 Years
Min: 3.97 Med: 5.37 Max: 7.86
Current: 4.74
During the past 13 years, the highest EV-to-Revenue of Thermo Fisher Scientific was 7.86. The lowest was 3.97. And the median was 5.37.
MIL:1TMO's EV-to-Revenue is ranked worse than 63.73% of 204
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.765
vs MIL:1TMO: 4.74
Thermo Fisher Scientific's share price for today is €408.40.
Thermo Fisher Scientific's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €103.08.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thermo Fisher Scientific EV-to-Revenue Related Terms
Thermo Fisher Scientific EV-to-Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1TMO vs DHR, IDXX, A: EV-to-Revenue Comparison
For the Diagnostics & Research subindustry, Thermo Fisher Scientific's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thermo Fisher Scientific EV-to-Revenue vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Thermo Fisher Scientific's EV-to-Revenue falls into.
Thermo Fisher Scientific's current Enterprise Value is €187,679 Mil.
Thermo Fisher Scientific's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €38,837 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thermo Fisher Scientific (MIL:1TMO) has a EV-to-Revenue of 4.83 as of Jun. 24, 2026. EV to Revenue ratio is the company's enterprise value divided by sales. View historical data on Thermo Fisher Scientific and its competitors. This is 10% below median its historical median of 5.37. Over the past decade, Thermo Fisher Scientific's EV-to-Revenue has ranged from 3.97 to 7.86. According to the industry distribution chart, Thermo Fisher Scientific ranks #130 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 63.7%.
Is Thermo Fisher Scientific's EV-to-Revenue too high?
Thermo Fisher Scientific's current EV-to-Revenue of 4.83 is 10% below median its 10-year median of 5.37. Over the past 10 years, this metric has ranged from a low of 3.97 to a high of 7.86. The Medical Diagnostics & Research industry median EV-to-Revenue is 2.77. Thermo Fisher Scientific's value of 4.83 is 74.7% above this industry median. Based on the distribution chart, Thermo Fisher Scientific ranks #130 out of 204 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Thermo Fisher Scientific has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's EV-to-Revenue compare to DHR and IDXX?
According to the Medical Diagnostics & Research industry distribution chart, Thermo Fisher Scientific ranks #130 out of 204 companies for EV-to-Revenue. This places Thermo Fisher Scientific in the lower half of its industry. The industry median EV-to-Revenue is 2.77. Thermo Fisher Scientific's value of 4.83 is 74.7% above this benchmark. Historically, Thermo Fisher Scientific's own EV-to-Revenue has ranged from 3.97 to 7.86 over the past decade. While the company's 10-year median is 5.37 vs. the industry median of 2.77, Thermo Fisher Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-Revenue for a Medical Diagnostics & Research company?
The median EV-to-Revenue among Medical Diagnostics & Research companies is 2.77, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-Revenue significantly above this median, while those in the bottom quartile fall well below. However, EV-to-Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Thermo Fisher Scientific's current EV-to-Revenue of 4.83 is 74.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-Revenue mean?
A high EV-to-Revenue can signal that a stock is expensive relative to its fundamentals. EV to Revenue ratio is the company's enterprise value divided by sales. View historical data on Thermo Fisher Scientific and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-Revenue is 2.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thermo Fisher Scientific's current EV-to-Revenue is 4.83, which is 10% below median its own 10-year median of 5.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (MIL:1TMO) is currently considered Modestly Undervalued. The stock's GF Value™ is €507.22, compared to a current price of €408.40 — trading 19.5% below its estimated fair value. The current EV-to-Revenue is 4.83, which is 10% below median its 10-year median of 5.37 and 74.7% above the Medical Diagnostics & Research industry median of 2.77. Thermo Fisher Scientific's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-Revenue calculated?
EV-to-Revenue is calculated from a company's financial statements. For Thermo Fisher Scientific (MIL:1TMO), the current EV-to-Revenue is 4.83 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Thermo Fisher Scientific (MIL:1TMO) Overvalued in 2026?
Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be undervalued.
The current stock price of €408.40 is trading 19.5% below its estimated GF Value™ of €507.22.
GuruFocus considers Thermo Fisher Scientific to be Modestly Undervalued.
Key valuation signals for MIL:1TMO:
EV-to-Revenue: 4.83 (10% below median its 10-year median of 5.37)
GF Value™: €507.22 vs. price of €408.40 (19.5% below fair value)
Industry Position: 74.7% above the Medical Diagnostics & Research median (#130 of 204)
No single metric tells the full story. See the MIL:1TMO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
57GF Score
Get the complete analysis for MIL:1TMO
EV-to-Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1TMO has been successfully added to your 
